A Highly Potent and Selective Caspase 1 Inhibitor that Utilizes a Key 3-Cyanopropanoic Acid Moiety

被引:72
作者
Boxer, Matthew B. [1 ]
Quinn, Amy M. [1 ]
Shen, Min [1 ]
Jadhav, Ajit [1 ]
Leister, William [1 ]
Simeonov, Anton [1 ]
Auld, Douglas S. [1 ]
Thomas, Craig J. [1 ]
机构
[1] NHGRI, NIH, NIH Chem Genom Ctr, Rockville, MD 20850 USA
基金
美国国家卫生研究院;
关键词
caspases; covalent modifiers; cysteine proteases; inhibitors; VRT-043198; VX-765; INTERLEUKIN-1-BETA CONVERTING-ENZYME; CYSTEINE PROTEASES; INFLAMMATORY CASPASES; IMMUNE-RESPONSES; MECHANISM; TETRAZOLES; NITRILES; TARGETS; TBCATB; VX-765;
D O I
10.1002/cmdc.200900531
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Herein, we examine the potential of a nitrile-containing propionic acid moiety as an electrophile for covalent attack by the active-site cysteine residue of caspase 1. The syntheses of several cyanopropanate-containing small molecules based on the, optimized peptidic scaffold of prodrug VX-765 were accomplished. These compounds were found to be potent inhibitors of caspase 1 (IC50 values <= 1 nM). Examination of these novel small molecules against a caspase panel demonstrated an impressive degree of selectivity for caspase 1 inhibition over other caspase isozymes. Assessment of hydrolytic stability and selected ADME properties highlighted these agents as potentially useful tools for studying caspase 1 down-regulation in various settings, including in vivo analyses.
引用
收藏
页码:730 / 738
页数:9
相关论文
共 32 条
  • [1] BATCHELOR MJ, 1999, Patent No. 5874424
  • [2] Targeting IL-1 in inflammatory disease: New opportunities for therapeutic intervention
    Braddock, M
    Quinn, A
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2004, 3 (04) : 1 - 10
  • [3] CAPRATHE BW, 1999, Patent No. 1999056765
  • [4] Inflammatory caspases: Targets for novel therapies
    Cornelis, Sigrid
    Kersse, Kristof
    Festjens, Nele
    Lamkanfi, Mohamed
    Vandenabeele, Peter
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2007, 13 (04) : 367 - 385
  • [5] Caspases: Keys in the ignition of cell death
    Denault, JB
    Salvesen, GS
    [J]. CHEMICAL REVIEWS, 2002, 102 (12) : 4489 - 4499
  • [6] PEPTIDE ALDEHYDES AND NITRILES AS TRANSITION-STATE ANALOG INHIBITORS OF CYSTEINE PROTEASES
    DUFOUR, E
    STORER, AC
    MENARD, R
    [J]. BIOCHEMISTRY, 1995, 34 (28) : 9136 - 9143
  • [7] Mammalian caspases: Structure, activation, substrates, and functions during apoptosis
    Earnshaw, WC
    Martins, LM
    Kaufmann, SH
    [J]. ANNUAL REVIEW OF BIOCHEMISTRY, 1999, 68 : 383 - 424
  • [8] Novel, nonpeptidic cyanamides as potent and reversible inhibitors of human cathepsins K and L
    Falgueyret, JP
    Oballa, RM
    Okamoto, O
    Wesolowski, G
    Aubin, Y
    Rydzewski, RM
    Prasit, P
    Riendeau, D
    Rodan, SB
    Percival, MD
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (01) : 94 - 104
  • [9] The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis
    Franchi, Luigi
    Eigenbrod, Tatjana
    Munoz-Planillo, Raul
    Nunez, Gabriel
    [J]. NATURE IMMUNOLOGY, 2009, 10 (03) : 241 - 247
  • [10] Recent advances in the synthesis, design and selection of cysteine protease inhibitors
    Hernandez, AA
    Roush, WR
    [J]. CURRENT OPINION IN CHEMICAL BIOLOGY, 2002, 6 (04) : 459 - 465